加州再生医学研究所独立公民监督委员会定期会议治理小组委员会。 根据加利福尼亚州干细胞研究与治疗法案组织。 将最新的 CIRM 新闻、即将召开的会议的信息以及资金机会发送到您的收件箱。

The maximum total funding for a DISC4 Award is $13 million per award. The maximum award duration is four years. Applicant Core Teams must be multi-institutional and include at least five California ...

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

The long-term objective of this project is to develop a drug to treat Huntington’s disease (HD), the most common inherited neurodegenerative disorder. Characterized by involuntary movements, ...

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

SFSU CIRM Bridges Science Master’s Program prepares talented and motivated graduate students for successful careers in the biomedical workforce in order to accelerate the discovery, development and ...

All experiments and manufacturing listed in the original application have been completed. We have submitted an IND to the FDA for a first-in-human Phase I clinical trial for late-onset adult Tay-Sachs ...

During this reporting period, significant progress was made in completing the study and preparing for its official close. The final monitoring visit took place in December 2024, ensuring that all data ...

年龄相关性黄斑变性 (AMD)、原发性开角型青光眼 (POAG) 和增殖性糖尿病视网膜病变 (PDR) 是全世界不可逆视力丧失的主要原因。尽管这些疾病的确切原因和机制尚不完全清楚，但众所周知，遗传和 ...

Through its strategic funding of clinical trials, CIRM helps advance innovative stem cell and gene therapy discoveries toward future treatments for patients. CIRM funds clinical trials across a broad ...

South San Francisco, CA, March 27, 2025 — The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, approved new and ...